TY - JOUR
T1 - Protective effect of sulforaphane on indomethacin-induced cytotoxicity via heme oxygenase-1expression in human intestinal Int 407 cells
AU - Yeh, Chi Tai
AU - Chiu, Hsiang Fan
AU - Yen, Gow Chin
PY - 2009
Y1 - 2009
N2 - Sulforaphane is known to be an indirect antioxidant that acts by inducing NF-E2-related factor 2 (Nrf2)-dependent phase II enzymes. In the present study, we investigated the effect of sulforaphane on the expression of heme oxygenase-1 (HO-1) in human intestinal Int 407 cells. RT-PCR and West- ern blot data revealed that sulforaphane induced an increase in HO-1 expression at the mRNA and protein levels, respectively. This induction was also marked by an increase in HO-1 activity. Actino- mycin D (an RNA synthesis inhibitor) and cycloheximide (a protein synthesis inhibitor) inhibited sul- foraphane-responsive HO-1 mRNA expression, indicating that sulforaphane is a requirement for tran- scription and de novo protein synthesis. Moreover, sulforaphane increased the nuclear levels of Nrf2 and increased the binding activity of nuclear proteins to the antioxidant responsive element consensus sequence. We also found that U0126, an ERK kinase inhibitor, suppressed the sulforaphane-induced HO-1 expression and nuclear translocation of Nrf2. Moreover, the cytoprotective effect of sulfora- phane on indomethancin-induced cytotoxicity was partially blocked by ERK and HO-1 inhibitors, fur- ther demonstrating that sulforaphane attenuated oxidative stress through a pathway that involved ERK and HO-1. Taken together, this study gives additional support to the possible use of sulforaphane as a dietary preventive agent against oxidative stress-induced intestinal injury.
AB - Sulforaphane is known to be an indirect antioxidant that acts by inducing NF-E2-related factor 2 (Nrf2)-dependent phase II enzymes. In the present study, we investigated the effect of sulforaphane on the expression of heme oxygenase-1 (HO-1) in human intestinal Int 407 cells. RT-PCR and West- ern blot data revealed that sulforaphane induced an increase in HO-1 expression at the mRNA and protein levels, respectively. This induction was also marked by an increase in HO-1 activity. Actino- mycin D (an RNA synthesis inhibitor) and cycloheximide (a protein synthesis inhibitor) inhibited sul- foraphane-responsive HO-1 mRNA expression, indicating that sulforaphane is a requirement for tran- scription and de novo protein synthesis. Moreover, sulforaphane increased the nuclear levels of Nrf2 and increased the binding activity of nuclear proteins to the antioxidant responsive element consensus sequence. We also found that U0126, an ERK kinase inhibitor, suppressed the sulforaphane-induced HO-1 expression and nuclear translocation of Nrf2. Moreover, the cytoprotective effect of sulfora- phane on indomethancin-induced cytotoxicity was partially blocked by ERK and HO-1 inhibitors, fur- ther demonstrating that sulforaphane attenuated oxidative stress through a pathway that involved ERK and HO-1. Taken together, this study gives additional support to the possible use of sulforaphane as a dietary preventive agent against oxidative stress-induced intestinal injury.
KW - Heme oxygenase
KW - Indomethacin
KW - Intestinal Int 407 cells
KW - Nonsteroidal anti-inflammatory drugs
KW - Sulforaphane
UR - http://www.scopus.com/inward/record.url?scp=70349639202&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=70349639202&partnerID=8YFLogxK
U2 - 10.1002/mnfr.200800558
DO - 10.1002/mnfr.200800558
M3 - Article
C2 - 19653226
AN - SCOPUS:70349639202
VL - 53
SP - 1166
EP - 1176
JO - Die Nahrung
JF - Die Nahrung
SN - 1613-4125
IS - 9
ER -